Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus’ U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies
Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as “Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to acquire Agenus Inc.'s (



